KLK3 and pachyonychia congenita: In recent years, several candidate promoter hypermethylation markers for PC diagnosis have been identified [5,6,7,8,9,10], some of which have also shown promising prognostic potential for prediction of prostate-specific antigen (PSA) recurrence after RP [5,6,8,11,12,13,14].